Berzenji Diako, Oude Booijink Olivier R G, Gahrmann Renske, Mast Hetty, Capala Marta E, Koppes Sjors A, van Meerten Esther, Kremer Bernd, Baatenburg de Jong Robert Jan, Offerman Marinella P J, Hardillo Jose A
Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus Medical Center (MC) Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Cancer. 2025 Jan 1;131(1):e35632. doi: 10.1002/cncr.35632. Epub 2024 Nov 5.
Patients with limited distant metastatic disease, also known as oligometastasis, show better survival rates than polymetastatic patients, and may be amenable for curative-intent treatment. The definition of oligometastasis, however, is unknown, and no quantitative analyses on the cutoff value for oligometastasis have been performed before. This study aims to derive specific threshold values for the number of metastases and affected locations that defines oligometastatic disease in head and neck squamous cell carcinoma.
A retrospective cohort study was conducted including all patients diagnosed with distant metastases between 2006 and 2021. For each patient, the number of distant metastases and affected locations was recorded on the basis of the available imaging at the time of diagnosis. Cox regression analyses and a machine-learning k-means algorithm were used to determine threshold values.
A total of 384 patients untreated for their metastatic foci were analyzed. Most patients (n = 207; 53.9%) had metastasis to one anatomic location, followed by metastases in two anatomic locations (n = 62; 16.1%). The majority of patients had ≥9 metastatic foci (n = 174; 45.3%), followed by one focus (n = 74; 19.3%) and two foci (n = 32; 8.3%). Cox regression and machine-learning k-means models showed that although the number of metastases did not predict survival, the number of affected locations did significantly (p < .001), by identifying a threshold of two locations.
Contrary to the prevalent dogma, the definition of oligometastasis should not be defined by the number of metastases but rather by the number of affected locations, with a maximum number of affected locations set at two.
远处转移病灶有限的患者,也称为寡转移患者,其生存率高于多转移患者,并且可能适合进行根治性治疗。然而,寡转移的定义尚不清楚,此前尚未对寡转移的临界值进行定量分析。本研究旨在得出头颈部鳞状细胞癌中定义寡转移疾病的转移灶数量和受累部位的具体阈值。
进行了一项回顾性队列研究,纳入2006年至2021年间所有诊断为远处转移的患者。对于每位患者,根据诊断时可用的影像学资料记录远处转移灶数量和受累部位。采用Cox回归分析和机器学习k均值算法来确定阈值。
共分析了384例未对转移灶进行治疗的患者。大多数患者(n = 207;53.9%)有一个解剖部位发生转移,其次是两个解剖部位发生转移(n = 62;16.1%)。大多数患者有≥9个转移灶(n = 174;45.3%),其次是一个转移灶(n = 74;19.3%)和两个转移灶(n = 32;8.3%)。Cox回归和机器学习k均值模型显示,虽然转移灶数量不能预测生存率,但受累部位数量有显著预测作用(p <.001),确定的阈值为两个部位。
与普遍观点相反,寡转移的定义不应由转移灶数量来界定,而应由受累部位数量来界定,受累部位的最大数量设定为两个。